Literature DB >> 23217086

Self-assessed health status changes in a community cohort of people with multiple sclerosis: 11 years of follow-up.

A Giordano1, G Ferrari, D Radice, G Randi, L Bisanti, A Solari.   

Abstract

BACKGROUND AND
PURPOSE: Few data are available on the health status of people with multiple sclerosis (PwMS) in the community. We assessed changes in self-perceived health status and health related quality of life of a community-based cohort of PwMS over a decade, and identified predictors of such changes.
METHODS: In 1999 we started the POSMOS study (Postal Survey of Self-Assessed Health of MS Adults and their Significant Others) on a random sample of 251 adults with MS from the Milan area (mean age 42 years, range 18-71 years), and prospectively assessed changes in self-perceived health status over 11 years. Participants completed the Multiple Sclerosis Quality-of-Life-54 (MSQOL-54) and a general/clinical questionnaire. We re-assessed the cohort in 2004 and 2010, sending the same questionnaires plus the Chicago Multiscale Depression Inventory.
RESULTS: There were 205 (86%) respondents in 2004, 171 (74%) in 2010; 28 (11%) died during the study. Severely impaired [self-determined Expanded Disability Status Scale (EDSS) > 6.5] increased from 19% to 32%. One-fifth remained fully ambulatory (EDSS <4.0): 25% women (median age 44 years [interquartile range, IQR 39-53], median years from diagnosis 16 [IQR 12-19]); and 17% men (median age 40 years [IQR 38-45], median years from diagnosis 14 [IQR 12-17]). Changes in MSQOL-54 composite scores were negligible; but among individual scales, change in health, cognitive function and general health worsened, and social function and emotional wellbeing improved significantly. Depressive symptoms were high and stable.
CONCLUSIONS: Multiple sclerosis had a pervasive but inhomogeneous impact on the lives of our MS sufferers. Notwithstanding overall clinical deterioration and aging, hospital admissions and medical consultations decreased, suggesting reduced use of health care resources. By contrast, housing adaptations and home care increased, psychological burden was high and self-perceived cognitive functioning worsened.
© 2012 The Author(s) European Journal of Neurology © 2012 EFNS.

Entities:  

Mesh:

Year:  2012        PMID: 23217086     DOI: 10.1111/ene.12028

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  9 in total

1.  Selected health behaviors moderate the progression of functional limitations in persons with multiple sclerosis: Eleven years of annual follow-up.

Authors:  Alexa K Stuifbergen; Shelley Blozis; Heather Becker; Tracie Harrison; Vicki Kullberg
Journal:  Disabil Health J       Date:  2016-01-28       Impact factor: 2.554

2.  Ten-year follow-up of health-related quality of life among ambulatory persons with multiple sclerosis at baseline.

Authors:  Aki Rintala; Arja Häkkinen; Jaana Paltamaa
Journal:  Qual Life Res       Date:  2016-06-30       Impact factor: 4.147

3.  Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventories.

Authors:  A M Giovannetti; E Pietrolongo; A Giordano; V Cimino; A Campanella; G Morone; A Fusco; A Lugaresi; P Confalonieri; F Patti; M G Grasso; M Ponzio; S Veronese; A Solari
Journal:  Qual Life Res       Date:  2016-04-28       Impact factor: 4.147

4.  Patient expression of emotions and neurologist responses in first multiple sclerosis consultations.

Authors:  Lidia Del Piccolo; Erika Pietrolongo; Davide Radice; Carla Tortorella; Paolo Confalonieri; Maura Pugliatti; Alessandra Lugaresi; Andrea Giordano; Christoph Heesen; Alessandra Solari
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

5.  Predictors of chronic cerebrospinal venous insufficiency procedure use among older people with multiple sclerosis: a national case-control study.

Authors:  Michelle Ploughman; Olivia J Manning; Serge Beaulieu; Chelsea Harris; Stephen H Hogan; Nancy Mayo; John D Fisk; A Dessa Sadovnick; Paul O'Connor; Sarah A Morrow; Luanne M Metz; Penelope Smyth; Penelope W Allderdice; Susan Scott; Ruth Ann Marrie; Mark Stefanelli; Marshall Godwin
Journal:  BMC Health Serv Res       Date:  2015-04-16       Impact factor: 2.655

6.  Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial.

Authors:  Alessandra Solari; Andrea Giordano; Maria Grazia Grasso; Paolo Confalonieri; Francesco Patti; Alessandra Lugaresi; Lucia Palmisano; Roberta Amadeo; Giovanni Martino; Michela Ponzio; Giuseppe Casale; Claudia Borreani; Renzo Causarano; Simone Veronese; Paola Zaratin; Mario Alberto Battaglia
Journal:  Trials       Date:  2015-04-23       Impact factor: 2.279

7.  The Canadian survey of health, lifestyle and ageing with multiple sclerosis: methodology and initial results.

Authors:  Michelle Ploughman; Serge Beaulieu; Chelsea Harris; Stephen Hogan; Olivia J Manning; Penelope W Alderdice; John D Fisk; A Dessa Sadovnick; Paul O'Connor; Sarah A Morrow; Luanne M Metz; Penelope Smyth; Nancy Mayo; Ruth Ann Marrie; Katherine B Knox; Mark Stefanelli; Marshall Godwin
Journal:  BMJ Open       Date:  2014-07-10       Impact factor: 2.692

8.  Changes in disability in people with multiple sclerosis: a 10-year prospective study.

Authors:  David Conradsson; Charlotte Ytterberg; Lena von Koch; Sverker Johansson
Journal:  J Neurol       Date:  2017-11-20       Impact factor: 4.849

9.  Participant perspectives of a home-based palliative approach for people with severe multiple sclerosis: A qualitative study.

Authors:  Ambra Mara Giovannetti; Claudia Borreani; Elisabetta Bianchi; Andrea Giordano; Sabina Cilia; Susanna Cipollari; Ilaria Rossi; Claudia Cavallaro; Valentina Torri Clerici; Edoardo Rossetti; Maria Consiglia Stefanelli; Amadio Totis; Angelo Pappalardo; Gina Occhipinti; Paolo Confalonieri; Simone Veronese; Maria Grazia Grasso; Francesco Patti; Paola Zaratin; Mario Alberto Battaglia; Alessandra Solari
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.